Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells
Quanri Jin(The University of Texas MD Anderson Cancer Center), Francisco J. Esteva(Northwell Health)
Cited by 137
Related Papers
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
|Clinical Chemistry|2008|1.1k
Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients
|Cancer|2011|291
PTEN, PIK3CA, p-AKT, and p-p70S6K Status
|American Journal Of Pathology|2010|285